Why America Doesn’t Trust the CDC

Why America Doesn’t Trust the CDC

Most remarkably, it didn’t seem to matter to the CDC that 75.2 percent of children under age 11 already have natural immunity, according to a CDC study that concluded in February. Natural immunity is certainly much more prevalent today, given the ubiquity of the Omicron variant since February. CDC data from New York and California demonstrated that natural immunity was 2.8 times more effective in preventing hospitalization and 3.3 to 4.7 times more effective in preventing COVID infection compared to vaccination during the Delta wave. These findings are consistent with dozens of other clinical studies. Yet natural immunity has consistently and inexplicably been dismissed by the medical establishment.

Public health officials are expected to recommend COVID vaccines for children under 5 as soon as June 21st, despite the fact that the vast majority of children already have natural immunity. In a recent Kaiser survey, only 18 percent of parents said they were eager to vaccinate their child in that age group.

1,287,595 Injuries Reported After COVID Shots, Vaccine Injury Compensation Programs ‘Overwhelmed’

VAERS data released Friday by the Centers for Disease Control and Prevention show 1,287,595 reports of adverse events from all age groups following COVID-19 vaccines, including 28,532 deaths and 235,041 serious injuries between Dec. 14, 2020, and May 27, 2022.

1,287,595 Injuries Reported After COVID Shots, Vaccine Injury Compensation Programs ‘Overwhelmed’

J&J pauses production of its Covid-19 vaccine despite persistent need 💰

J&J pauses production of its Covid-19 vaccine despite persistent need

The facility, in the Dutch city of Leiden, has instead been making an experimental but potentially more profitable vaccine to protect against an unrelated virus.

But poorer countries remain reliant on Johnson & Johnson’s vaccine, which does not require ultracold refrigeration. It has been shown to provide strong and long-lasting protection against severe disease across variants, including omicron, when given as a two-shot regimen. As a single shot, the vaccine is less expensive and relatively easy to give to hard-to-reach populations.

Unlike companies such as Pfizer and Moderna, which have reaped billions of dollars in profits, Johnson & Johnson did not find the COVID vaccine to be a big moneymaker.

….

Since production of the COVID vaccine was halted late last year, the Netherlands plant has been manufacturing an experimental vaccine against respiratory syncytial virus, or RSV, that will be used for a clinical trial in older adults in wealthy countries, a person familiar with the matter said. Even if it proves effective, the vaccine is not expected to become available for several years.

U.S. J&J Covid vaccine doses will be sent to Thailand-Myanmar border

U.S. J&J Covid vaccine doses will be sent to Thailand-Myanmar border

Millions of Johnson & Johnson doses have been sitting in warehouses since Emergent BioSolutions, a contract manufacturer, accidentally botched 15 million doses of the shot by mixing it with the AstraZeneca drug substance. Over the last several months, the Food and Drug Administration has investigated the batches and cleared them for use.